Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

During a panel discussion at this year’s Fierce JPM Week—which took place alongside the annual J.P. | This week on “The Top ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) has shared an announcement. Shanghai Henlius Biotech, Inc. announced a change in its board ...

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they ...